Brind.

Soleno Therapeutics, a company in the medical drugs industry, outperformed S&P 500 stock gains on August 7, 2025.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Soleno Therapeutics, a company in the medical drugs industry, outperformed S&P 500 stock gains on August 7, 2025.

Who's involved

What this event is mainly about
Soleno Therapeutics (United States)

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksSoleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates Soleno Therapeutics, Inc. (SLNO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a lo